Integrative Cognitive-Affective Therapy for Binge Eating Disorder
Status: | Completed |
---|---|
Conditions: | Psychiatric, Psychiatric, Eating Disorder |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - 65 |
Updated: | 5/6/2018 |
Start Date: | December 2013 |
End Date: | August 2017 |
The purpose of the study is to test a newly developed individual psychotherapy treatment for
binge eating disorder in adults. This treatment is a type of individual psychotherapy called
Integrative Cognitive-Affective Therapy (ICAT) that focuses on helping people change their
behaviors, feelings, thoughts about themselves, and relationships. This new treatment is
being compared to an existing treatment called Cognitive-Behavior Therapy-Guided Self Help
(CBTgsh), which focuses on changing behavior patterns through the use of reading and homework
assignments along with sessions with a therapist. The primary hypothesis of this
investigation is that ICAT will be associated with greater reductions in binge eating at end
of treatment and follow-up compared to CBTgsh.
binge eating disorder in adults. This treatment is a type of individual psychotherapy called
Integrative Cognitive-Affective Therapy (ICAT) that focuses on helping people change their
behaviors, feelings, thoughts about themselves, and relationships. This new treatment is
being compared to an existing treatment called Cognitive-Behavior Therapy-Guided Self Help
(CBTgsh), which focuses on changing behavior patterns through the use of reading and homework
assignments along with sessions with a therapist. The primary hypothesis of this
investigation is that ICAT will be associated with greater reductions in binge eating at end
of treatment and follow-up compared to CBTgsh.
Inclusion Criteria:
- Binge eating disorder (DSM-5)
Exclusion Criteria:
- History of gastric bypass surgery
- Medical condition acutely affecting eating and/or weight
- Current medical and/or psychiatric instability (e.g., acute suicidality)
- Psychosis and/or bipolar disorder
- Severe cognitive impairment or developmental disability
- Inability to read English
- Current substance use disorder
- Current participation in psychotherapy and/or commercial weight loss program
- Change in dosage and/or frequency of psychotropic medication in the past 6 weeks
- Pregnant or breast feeding
- BMI < 21
We found this trial at
2
sites
Fargo, North Dakota 58107
Principal Investigator: Stephen A Wonderlich, PhD
Phone: 701-365-4910
Click here to add this to my saved trials
Minneapolis, Minnesota 55455
(612) 625-5000
Principal Investigator: Carol B Peterson, PhD
Phone: 612-273-9811
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
Click here to add this to my saved trials